(Circulation. 1997;96:2795-2801.)
© 1997 American Heart Association, Inc.
Articles |
From the Cardiology Branch and Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.
Correspondence to Dr Richard O. Cannon III, National Institutes of Health, Bldg 10, Room 7B15, 10 Center Dr MSC1650, Bethesda, MD 20892-1650.
Background At physiological concentrations, 17ß-estradiol selectively enhances endothelium-dependent coronary vasodilation by an unknown mechanism in postmenopausal women.
Methods and Results To assess the contribution of nitric oxide (NO) to the vascular effects of estradiol, we measured coronary epicardial and microvascular responses to intracoronary acetylcholine (range, 3 to 300 µg/min for 2 minutes) before and after intracoronary estradiol 75 ng/min for 15 minutes in 20 estrogen-deficient women, 16 of whom had angiographic evidence of atherosclerosis or risk factors for atherosclerosis. This testing was repeated after inhibition of NO synthesis with intracoronary NG-monomethyl-L-arginine (L-NMMA) 64 µmol/min for 5 minutes. Estradiol increased acetylcholine-stimulated coronary flow from 54±48% (mean±SD) above baseline values before estradiol infusion to 100±63% above baseline values (P=.007) and decreased coronary resistance from 32±21% to 46±15% below baseline values (P=.007) at a coronary sinus estradiol concentration of 1725±705 pmol/L (470±192 pg/mL). Estradiol also tended to lessen the severity of acetylcholine-induced epicardial coronary artery vasoconstriction from 8±11% to 3±11% below baseline values (P=.123). However, during L-NMMA infusion, estradiol no longer potentiated the effects of acetylcholine on coronary flow dynamics; coronary flow increased 39±46% above baseline values and coronary resistance decreased 19±30% below baseline values (both P<.001 versus preL-NMMA responses). The epicardial diameter decreased 8±11% below baseline values (P=.06 versus preL-NMMA response).
Conclusions The effects of estradiol at physiological concentrations on endothelium-dependent coronary vasodilator responsiveness in postmenopausal women are mediated by enhanced bioavailability of NO, which may be responsible in part for the cardioprotective effects of estrogen.
Key Words: atherosclerosis coronary disease nitric oxide endothelium hormones
This article has been cited by other articles:
![]() |
D. Z. I. Cherney, J. W. Scholey, D. C. Cattran, A. K. Kang, J. Zimpelmann, C. Kennedy, V. Lai, K. D. Burns, and J. A. Miller The effect of oral contraceptives on the nitric oxide system and renal function Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1539 - F1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kreijkamp-Kaspers, L. Kok, M. L Bots, D. E Grobbee, J. W Lampe, and Y. T van der Schouw Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women Am. J. Clinical Nutrition, January 1, 2005; 81(1): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. De Souza and N. I. Williams Physiological aspects and clinical sequelae of energy deficiency and hypoestrogenism in exercising women Hum. Reprod. Update, September 1, 2004; 10(5): 433 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Juan, J.-J. Chen, C.-H. Chen, H. Lin, C.-F. Cheng, J.-C. Liu, M.-H. Hsieh, Y.-L. Chen, H.-H. Chao, T.-H. Chen, et al. 17{beta}-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1254 - H1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Widder, T. Pelzer, C. von Poser-Klein, K. Hu, V. Jazbutyte, K.-H. Fritzemeier, C. Hegele-Hartung, L. Neyses, and J. Bauersachs Improvement of Endothelial Dysfunction by Selective Estrogen Receptor-{alpha} Stimulation in Ovariectomized SHR Hypertension, November 1, 2003; 42(5): 991 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Colacurci, D. Manzella, F. Fornaro, M. Carbonella, and G. Paolisso Endothelial Function and Menopause: Effects of Raloxifene Administration J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2135 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cavasin, S. S. Sankey, A.-L. Yu, S. Menon, and X.-P. Yang Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1560 - H1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Laufs, O. Adam, K. Strehlow, S. Wassmann, C. Konkol, K. Laufs, W. Schmidt, M. Bohm, and G. Nickenig Down-regulation of Rac-1 GTPase by Estrogen J. Biol. Chem., February 14, 2003; 278(8): 5956 - 5962. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Simoncini, E. Rabkin, and J. K. Liao Molecular Basis of Cell Membrane Estrogen Receptor Interaction With Phosphatidylinositol 3-Kinase in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Gladwin, A. N. Schechter, F. P. Ognibene, W. A. Coles, C. D. Reiter, W. H. Schenke, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease Circulation, January 21, 2003; 107(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Haynes, L. Li, D. Sinha, K. S. Russell, K. Hisamoto, R. Baron, M. Collinge, W. C. Sessa, and J. R. Bender Src Kinase Mediates Phosphatidylinositol 3-Kinase/Akt-dependent Rapid Endothelial Nitric-oxide Synthase Activation by Estrogen J. Biol. Chem., January 17, 2003; 278(4): 2118 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Lee, T.-F. Chou, and C.-H. Tsai Differential Role of KATP Channels Activated by Conjugated Estrogens in the Regulation of Myocardial and Coronary Protective Effects Circulation, January 7, 2003; 107(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge Estrogen Reduces Angiotensin II-Induced Nitric Oxide Synthase and NAD(P)H Oxidase Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Bell, K. E. Gochenaur, and J. Hecht O2--mediated impairment of coronary arterial relaxation is prevented by overnight treatment with 1 nM beta -estradiol J Appl Physiol, December 1, 2002; 93(6): 1952 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Chambliss and P. W. Shaul Estrogen Modulation of Endothelial Nitric Oxide Synthase Endocr. Rev., October 1, 2002; 23(5): 665 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Polvani, M. R. Marino, M. Roberto, L. Dainese, A. Parolari, G. Pompilio, S. D. Matteo, A. Fumero, A. Cannata, F. Barili, et al. Acute effects of 17{beta}-estradiol on left internal mammary graft after coronary artery bypass grafting Ann. Thorac. Surg., September 1, 2002; 74(3): 695 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Mershon, R. S. Baker, and K. E. Clark Estrogen increases iNOS expression in the ovine coronary artery Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1169 - H1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh Effects of estrogen on the vascular wall: vasomotor function and inflammation Cardiovasc Res, September 1, 2002; 55(4): 714 - 726. [Full Text] [PDF] |
||||
![]() |
A.C. Duncan, J.R. Petrie, M.J. Brosnan, A.M. Devlin, R.A. Bass, D.S. Charnock-Jones, J.M.C. Connell, A.F. Dominiczak, and M.A. Lumsden Is estradiol cardioprotection a nitric oxide-mediated effect? Hum. Reprod., July 1, 2002; 17(7): 1918 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Rosenbaum, M. Pretorius, J. V. Gainer, D. Byrne, L. J. Murphey, C. A. Painter, D. E. Vaughan, and N. J. Brown Ethnicity Affects Vasodilation, but Not Endothelial Tissue Plasminogen Activator Release, in Response to Bradykinin Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 1023 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fischer, A. Baessler, and H. Schunkert Renin angiotensin system and gender differences in the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 672 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dubey, S. Oparil, B. Imthurn, and E. K. Jackson Sex hormones and hypertension Cardiovasc Res, February 15, 2002; 53(3): 688 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Waters, M. G. Ziegler, and J. V. Meck Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance J Appl Physiol, February 1, 2002; 92(2): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. N. Das Nitric Oxide as the Mediator of the Antiosteoporotic Actions of Estrogen, Statins, and Essential Fatty Acids Experimental Biology and Medicine, February 1, 2002; 227(2): 88 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chidambaram, J. A. Duncan, V. S. Lai, D. C. Cattran, J. S. Floras, J. W. Scholey, and J. A. Miller Variation in the Renin Angiotensin System throughout the Normal Menstrual Cycle J. Am. Soc. Nephrol., February 1, 2002; 13(2): 446 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, Z. Bian, P. Lu, R. H. Karas, L. Bao, D. Cox, J. Hodgin, P. W. Shaul, P. Thoren, O. Smithies, et al. Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor beta Science, January 18, 2002; 295(5554): 505 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Schulman, D. R. Thiemann, P. Ouyang, N. C. Chandra, D. S. Schulman, S. E. Reis, M. Terrin, S. Forman, C. Piva de Albuquerque, R. D. Bahr, et al. Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina J. Am. Coll. Cardiol., January 16, 2002; 39(2): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Waters Estrogen therapy for unstable angina: Another bump for the bandwagon J. Am. Coll. Cardiol., January 16, 2002; 39(2): 238 - 240. [Full Text] [PDF] |
||||
![]() |
M. G. Shlipak, B. G. Angeja, A. S. Go, P. D. Frederick, J. G. Canto, and D. Grady Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women Circulation, November 6, 2001; 104(19): 2300 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sitges, M Heras, E Roig, M Duran, M Masotti, M.J Zurbano, M Roque, and G Sanz Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries Eur. Heart J., November 2, 2001; 22(22): 2116 - 2124. [Abstract] [PDF] |
||||
![]() |
K. K. Koh, M. H. Kang, D. K. Jin, S.-K. Lee, J. Y. Ahn, H. Y. Hwang, S. H. Yang, D. S. Kim, T. H. Ahn, and E. K. Shin Vascular effects of estrogen in type II diabetic postmenopausal women J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. WAGNER, M. R. SCHROETER, and M. HECKER 17{beta}-Estradiol inhibition of NADPH oxidase expression in human endothelial cells FASEB J, October 1, 2001; 15(12): 2121 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh, D. K. Jin, S. H. Yang, S.-K. Lee, H. Y. Hwang, M. H. Kang, W. Kim, D. S. Kim, I. S. Choi, and E. K. Shin Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women Circulation, April 17, 2001; 103(15): 1961 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Walker, T. S. Dean, T. A. B. Sanders, G. Jackson, J. M. Ritter, and P. J. Chowienczyk The Phytoestrogen Genistein Produces Acute Nitric Oxide-Dependent Dilation of Human Forearm Vasculature With Similar Potency to 17{beta}-Estradiol Circulation, January 16, 2001; 103(2): 258 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Laughlin, W. G. Schrage, R. M. McAllister, H. A. Garverick, and A. W. Jones Interaction of gender and exercise training: vasomotor reactivity of porcine skeletal muscle arteries J Appl Physiol, January 1, 2001; 90(1): 216 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text] |
||||
![]() |
S. Vehkavaara, J. Westerbacka, T. Hakala-Ala-Pietilä, A. Virkamäki, O. Hovatta, and H. Yki-Järvinen Effect of Estrogen Replacement Therapy on Insulin Sensitivity of Glucose Metabolism and Preresistance and Resistance Vessel Function in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4663 - 4670. [Abstract] [Full Text] |
||||
![]() |
P. Angerer, W. Kothny, S. Stork, and C. von Schacky Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zanger, B. K. Yang, J. Ardans, M. A. Waclawiw, G. Csako, L. M. Wahl, and R. O. Cannon III Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1797 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Haynes, D. Sinha, K. S. Russell, M. Collinge, D. Fulton, M. Morales-Ruiz, W. C. Sessa, and J. R. Bender Membrane Estrogen Receptor Engagement Activates Endothelial Nitric Oxide Synthase via the PI3-Kinase-Akt Pathway in Human Endothelial Cells Circ. Res., October 13, 2000; 87(8): 677 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Webb, M. A. Ghatei, J. G. McNeill, DCRR, and P. Collins 17{beta}-Estradiol Decreases Endothelin-1 Levels in the Coronary Circulation of Postmenopausal Women With Coronary Artery Disease Circulation, October 3, 2000; 102(14): 1617 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Stefano, P. Cadet, C. Breton, Y. Goumon, V. Prevot, J. P. Dessaint, J.-C. Beauvillain, A. S. Roumier, I. Welters, and M. Salzet Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor Blood, June 15, 2000; 95(12): 3951 - 3958. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Herrington, B. E. Pusser, W. A. Riley, T. Y. Thuren, K. B. Brosnihan, E. A. Brinton, and D. B. MacLean Cardiovascular Effects of Droloxifene, a New Selective Estrogen Receptor Modulator, in Healthy Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1606 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Stefano, V. Prevot, J.-C. Beauvillain, P. Cadet, C. Fimiani, I. Welters, G. L. Fricchione, C. Breton, P. Lassalle, M. Salzet, et al. Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia Circulation, April 4, 2000; 101(13): 1594 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Majmudar, S. C. Robson, and G. A. Ford Effects of the Menopause, Gender, and Estrogen Replacement Therapy on Vascular Nitric Oxide Activity J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1577 - 1583. [Abstract] [Full Text] |
||||
![]() |
S Manzi, L H Kuller, D Edmundowicz, and K Sutton-Tyrrell Vascular imaging: changing the face of cardiovascular research Lupus, March 1, 2000; 9(3): 176 - 182. [Abstract] [PDF] |
||||
![]() |
K. S. Russell, M. P. Haynes, T. Caulin-Glaser, J. Rosneck, W. C. Sessa, and J. R. Bender Estrogen Stimulates Heat Shock Protein 90 Binding to Endothelial Nitric Oxide Synthase in Human Vascular Endothelial Cells. EFFECTS ON CALCIUM SENSITIVITY AND NO RELEASE J. Biol. Chem., February 18, 2000; 275(7): 5026 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rinder, R. J. Spina, and A. A. Ehsani Enhanced endothelium-dependent vasodilation in older endurance-trained men J Appl Physiol, February 1, 2000; 88(2): 761 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blum, L. Hathaway, R. Mincemoyer, W. H. Schenke, M. Kirby, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women J. Am. Coll. Cardiol., February 1, 2000; 35(2): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Karas, J. B. Hodgin, M. Kwoun, J. H. Krege, M. Aronovitz, W. Mackey, J. A. Gustafsson, K. S. Korach, O. Smithies, and M. E. Mendelsohn Estrogen inhibits the vascular injury response in estrogen receptor beta -deficient female mice PNAS, December 21, 1999; 96(26): 15133 - 15136. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. New, S. J. Duffy, R. W. Harper, and I. T. Meredith Estrogen improves acetylcholine-induced but not metabolic vasodilation in biological males Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2341 - H2347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Duran, T. de Frutos, J. Diaz-Recasens, G. Garcia-Galvez, A. Jimenez, M. Monton, J. Farre, L. S. de Miguel, F. Gonzalez-Fernandez, M. d. M. Arriero, et al. Estrogen Stimulates Neuronal Nitric Oxide Synthase Protein Expression in Human Neutrophils Circ. Res., November 26, 1999; 85(11): 1020 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh, A. Blum, L. Hathaway, R. Mincemoyer, G. Csako, M. A. Waclawiw, J. A. Panza, and R. O. Cannon III Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal Women Circulation, November 2, 1999; 100(18): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Stefano, V. Prevot, J.-C. Beauvillain, C. Fimiani, I. Welters, P. Cadet, C. Breton, J. Pestel, M. Salzet, and T. V. Bilfinger Estradiol Coupling to Human Monocyte Nitric Oxide Release Is Dependent on Intracellular Calcium Transients: Evidence for an Estrogen Surface Receptor J. Immunol., October 1, 1999; 163(7): 3758 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Anderson Assessment and treatment of endothelial dysfunction in humans J. Am. Coll. Cardiol., September 1, 1999; 34(3): 631 - 638. [Full Text] [PDF] |
||||